ApprovalTrail

Drug · DIN 02539977

AXBERI

SINGLE-USE PREFILLED SYRINGE

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since October 15, 2024; first marketed October 15, 2024.
Drug Identification Number (DIN)
02539977
Company (DIN owner)
Baxter CorporationMississauga, Ontario, Canada
Schedule
Prescription
Dosage form
Solution
Route
Subcutaneous; Intravenous
Therapeutic class (ATC)
Enoxaparin B01AB05
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
ENOXAPARIN SODIUM30 MG0.3 ML

Other DINs named AXBERI